Literature DB >> 10467410

Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

U S Khoo1, H Ozcelik, A N Cheung, L W Chow, H Y Ngan, S J Done, A C Liang, V W Chan, G K Au, W F Ng, C S Poon, Y F Leung, F Loong, P Ip, G S Chan, I L Andrulis, J Lu, F C Ho.   

Abstract

Inherited mutations in the BRCA1 gene confer increased susceptibility to breast and ovarian cancer. Its role in sporadic carcinogenesis is not well defined. Somatic mutations in breast cancers have not been reported and to date there are only three reports of somatic mutations in sporadic ovarian cancers. To investigate the contribution of BRCA1 mutations to sporadic breast and ovarian cancer in the Chinese population, we analysed 62 samples from Chinese women using the protein truncation test. There were 40 cases of breast cancer under age 50 and 22 cases of ovarian cancer, all unselected for family history. There was no age selection for the ovarian cancers. We found two somatic BRCA1 mutations in exon 11, one in a breast cancer and the other in an ovarian cancer, both of which result in truncated proteins. Our results indicate that somatic BRCA1 mutations, like somatic mutations in the BRCA2 gene, though very rare, can be found in both breast and ovarian cancers and support a tumor suppressor function for BRCA1 in sporadic tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467410     DOI: 10.1038/sj.onc.1202847

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

Review 1.  Emerging roles of BRCA1 alternative splicing.

Authors:  T I Orban; E Olah
Journal:  Mol Pathol       Date:  2003-08

2.  Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.

Authors:  K Y-K Chan; W Liu; J-R Long; S-P Yip; S-Y Chan; X-O Shu; D T-T Chua; A N-Y Cheung; J C-Y Ching; H Cai; G K-H Au; M Chan; W Foo; H Y-S Ngan; Y-T Gao; E S-W Ngan; M-M Garcia-Barceló; Wei Zheng; U-S Khoo
Journal:  J Med Genet       Date:  2008-09-09       Impact factor: 6.318

3.  Expression of EMSY gene in sporadic ovarian cancer.

Authors:  Julide Altinisik; Ates Karateke; Hakan Coksuer; Turgut Ulutin; Nur Buyru
Journal:  Mol Biol Rep       Date:  2010-03-28       Impact factor: 2.316

Review 4.  Breast cancer epigenetics: normal human mammary epithelial cells as a model system.

Authors:  Rebecca A Hinshelwood; Susan J Clark
Journal:  J Mol Med (Berl)       Date:  2008-08-21       Impact factor: 4.599

5.  Expanding the spectrum of germline variants in cancer.

Authors:  Abdul K Siraj; Tariq Masoodi; Rong Bu; Sandeep Kumar Parvathareddy; Ismail A Al-Badawi; Nasser Al-Sanea; Luai H Ashari; Alaa Abduljabbar; Samar Alhomoud; Saif S Al-Sobhi; Asma Tulbah; Dahish Ajarim; Khalid Alzoman; Muna Aljuboury; Hussam Bin Yousef; Mohammed Al-Dawish; Fouad Al-Dayel; Fowzan S Alkuraya; Khawla S Al-Kuraya
Journal:  Hum Genet       Date:  2017-10-03       Impact factor: 4.132

Review 6.  An Overview of PARP Inhibitors for the Treatment of Breast Cancer.

Authors:  Laura Cortesi; Hope S Rugo; Christian Jackisch
Journal:  Target Oncol       Date:  2021-03-12       Impact factor: 4.493

7.  Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.

Authors:  M Georgitsi; A Karhu; R Winqvist; T Visakorpi; K Waltering; P Vahteristo; V Launonen; L A Aaltonen
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

8.  Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies.

Authors:  Li Zhang; Xinghua Long
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

Review 9.  Hereditary breast cancer: clinical, pathological and molecular characteristics.

Authors:  Martin J Larsen; Mads Thomassen; Anne-Marie Gerdes; Torben A Kruse
Journal:  Breast Cancer (Auckl)       Date:  2014-10-15

Review 10.  The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer.

Authors:  Marcia L McCoy; Christopher R Mueller; Calvin D Roskelley
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.